Lenskart Solutions (NSE:LENSKART) ROC (Joel Greenblatt) %: 24.44% (As of Mar. 2026) — 123% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LENSKART Lenskart Solutions Ltd NSE:LENSKART
11 GF Score
Price ₹568.35
! 3 Warning Signs
View Full Analysis

What is Lenskart Solutions ROC (Joel Greenblatt) %?

Lenskart Solutions NSE:LENSKART -0.32% 11 ROC (Joel Greenblatt) % is 24.44% as of Mar. 2026, which is 123% above its 10-year median of 10.95. GuruFocus rates NSE:LENSKART with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Lenskart Solutions ranks better than 64.68% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Lenskart Solutions's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 24.44%.

The historical rank and industry rank for Lenskart Solutions's ROC (Joel Greenblatt) % or its related term are showing as below:

NSE:LENSKART' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2.03   Med: 10.95   Max: 19.56
Current: 16.11

During the past 4 years, Lenskart Solutions's highest ROC (Joel Greenblatt) % was 19.56%. The lowest was -2.03%. And the median was 10.95%.

NSE:LENSKART's ROC (Joel Greenblatt) % is ranked better than
64.68% of 838 companies
in the Medical Devices & Instruments industry
Industry Median: 4.6 vs NSE:LENSKART: 16.11

Lenskart Solutions's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Lenskart Solutions  (NSE:LENSKART) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Lenskart Solutions ROC (Joel Greenblatt) % Related Terms


Lenskart Solutions ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Lenskart Solutions's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lenskart Solutions ROC (Joel Greenblatt) % Chart

Lenskart Solutions Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROC (Joel Greenblatt) %
-2.03 7.25 14.65 19.56

Lenskart Solutions Quarterly Data
Mar23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial 0.00 29.50 16.76 22.00 24.44

NSE:LENSKART vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison

For the Medical Instruments & Supplies subindustry, Lenskart Solutions's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lenskart Solutions ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lenskart Solutions's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Lenskart Solutions's ROC (Joel Greenblatt) % falls into.


NSE:LENSKART
11GF Score
Lenskart Solutions Ltd NSE:LENSKART
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lenskart Solutions ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1747.17 + 10370.04 + 7009.04) - (13995.07 + 0 + 3443.16)
=1688.02

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Lenskart Solutions for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=11909.32/( ( (0 + max(0, 0)) + (47048.19 + max(1688.02, 0)) )/ 1 )
=11909.32/( ( 0 + 48736.21 )/ 1 )
=11909.32/48736.21
=24.44 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 24.44% mean?
Lenskart Solutions (NSE:LENSKART) has a ROC (Joel Greenblatt) % of 24.44% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lenskart Solutions and its competitors. This is 123% above median its historical median of 10.95. According to the industry distribution chart, Lenskart Solutions ranks #296 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 35.3%.
Is Lenskart Solutions' ROC (Joel Greenblatt) % too high?
Lenskart Solutions' current ROC (Joel Greenblatt) % of 24.44% is 123% above median its 10-year median of 10.95. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.60. Lenskart Solutions' value of 24.44% is 431.3% above this industry median. Based on the distribution chart, Lenskart Solutions ranks #296 out of 838 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lenskart Solutions has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Lenskart Solutions' ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lenskart Solutions ranks #296 out of 838 companies for ROC (Joel Greenblatt) %. This puts Lenskart Solutions in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 4.60. Lenskart Solutions' value of 24.44% is 431.3% above this benchmark. While the company's 10-year median is 10.95 vs. the industry median of 4.60, Lenskart Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.60, based on 838 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lenskart Solutions's current ROC (Joel Greenblatt) % of 24.44% is 431.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Lenskart Solutions and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lenskart Solutions's current ROC (Joel Greenblatt) % is 24.44%, which is 123% above median its own 10-year median of 10.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lenskart Solutions stock overvalued right now?
Lenskart Solutions (NSE:LENSKART) has a current ROC (Joel Greenblatt) % of 24.44%. The current ROC (Joel Greenblatt) % is 24.44%, which is 123% above median its 10-year median of 10.95 and 431.3% above the Medical Devices & Instruments industry median of 4.60. Lenskart Solutions' overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Lenskart Solutions (NSE:LENSKART), the current ROC (Joel Greenblatt) % is 24.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lenskart Solutions Business Description

Other Exchanges 544600:India
Address Golf Course Road, Ground Floor, Vipul Tech Square, Sector- 43, Gurugram, HR, IND, 122009
Lenskart Solutions Ltd is a technology-driven eyewear company, with a belief that clear vision is fundamental to personal development and well-being. It sells a range of eyewear products including prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories.
11GF Score

Get the complete analysis for NSE:LENSKART

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹568.35
Price